Cherry C. Ho, Ph.D. - Publications

Affiliations: 
Columbia University, New York, NY 
Area:
neurology

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Kett LR, Boassa D, Ho CC, Rideout HJ, Hu J, Terada M, Ellisman M, Dauer WT. LRRK2 Parkinson disease mutations enhance its microtubule association. Human Molecular Genetics. 21: 890-9. PMID 22080837 DOI: 10.1093/Hmg/Ddr526  0.55
2011 Droggiti A, Ho CC, Stefanis L, Dauer WT, Rideout HJ. Targeted disruption of neuronal 19S proteasome subunits induces the formation of ubiquitinated inclusions in the absence of cell death. Journal of Neurochemistry. 119: 630-43. PMID 21883213 DOI: 10.1111/j.1471-4159.2011.07444.x  0.517
2009 Jorgensen ND, Peng Y, Ho CC, Rideout HJ, Petrey D, Liu P, Dauer WT. The WD40 domain is required for LRRK2 neurotoxicity. Plos One. 4: e8463. PMID 20041156 DOI: 10.1371/Journal.Pone.0008463  0.551
2009 Ho CC, Rideout HJ, Ribe E, Troy CM, Dauer WT. The Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals via Fas-associated protein with death domain and caspase-8 in a cellular model of neurodegeneration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 1011-6. PMID 19176810 DOI: 10.1523/JNEUROSCI.5175-08.2009  0.572
Show low-probability matches.